Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Xavier de Lamballerie and Caroline Solas.
Xavier de Lamballerie
Connection Strength
0.337
Caroline Solas
  1. Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2. Antiviral Res. 2021 09; 193:105137.
    View in: PubMed
    Score: 0.060
  2. Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model. Nat Commun. 2021 03 19; 12(1):1735.
    View in: PubMed
    Score: 0.058
  3. SARS-CoV-2 viral dynamics in non-human primates. PLoS Comput Biol. 2021 03; 17(3):e1008785.
    View in: PubMed
    Score: 0.058
  4. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates. Nature. 2020 09; 585(7826):584-587.
    View in: PubMed
    Score: 0.056
  5. Dose Rationale for Favipiravir Use in Patients Infected With SARS-CoV-2. Clin Pharmacol Ther. 2020 08; 108(2):188.
    View in: PubMed
    Score: 0.055
  6. Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies. Nat Commun. 2018 10 01; 9(1):4013.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.